Growth hacking
from24/7 Wall St.
3 months agoHims & Hers Shows It's More Than Just GLP-1 Drugs
Hims & Hers posted a substantial growth in revenue and profits, leading to an 18% stock surge.
The company is focusing on long-term growth with significant increase in subscribers and monetization.